Expanded Access Program (EAP) STIMULAN VG (EAPSTIMVG)

Biocomposites Ltd

Status

Conditions: Stage IV Pressure Ulcer; Diabetic Foot Osteomyelitis

Treatments: Combination Product: STIMULAN VG

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT06808568

EAPSTIMVG

Details and patient eligibility

About

Individual (single) patient expanded access may be considered.

Full description

Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers.

Under these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient.

Please contact [e-mail] for more information.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria